130 related articles for article (PubMed ID: 17944348)
1. Evaluation of an anemia algorithm in chronic hemodialysis patients.
Nhan J; Jensen L; McMahon A
CANNT J; 2007; 17(3):48-58, 62-73; quiz 59-61, 74-6. PubMed ID: 17944348
[TBL] [Abstract][Full Text] [Related]
2. Cost savings using a protocol approach to manage anemia in a hemodialysis unit.
Charlesworth EC; Richardson RM; Battistella M
Am J Nephrol; 2014; 39(6):509-14. PubMed ID: 24903565
[TBL] [Abstract][Full Text] [Related]
3. Anemia management protocols: providing consistent hemoglobin outcomes.
Michael M
Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
[TBL] [Abstract][Full Text] [Related]
4. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
Yong K; Kairaitis L
Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
[TBL] [Abstract][Full Text] [Related]
5. A successful anaemia management algorithm that achieves and maintains optimum haemoglobin status.
Benton S
J Ren Care; 2008 Jun; 34(2):54-8. PubMed ID: 18498568
[TBL] [Abstract][Full Text] [Related]
6. Changing patterns of anemia management in US hemodialysis patients.
Freburger JK; Ng LJ; Bradbury BD; Kshirsagar AV; Brookhart MA
Am J Med; 2012 Sep; 125(9):906-14.e9. PubMed ID: 22938926
[TBL] [Abstract][Full Text] [Related]
7. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
Besarab A; Dalton CL
Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of a team-led treatment protocol for the management of renal anaemia.
Kotwal SS; Lan P; MacLeod A; Jardine M; Snelling P; Craig J; Cass A; Gallagher M
Nephrology (Carlton); 2013 Oct; 18(10):649-54. PubMed ID: 23889845
[TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
10. A predictive algorithm for the management of anaemia in haemodialysis patients based on ESA pharmacodynamics: better results for less work.
Lines SW; Lindley EJ; Tattersall JE; Wright MJ
Nephrol Dial Transplant; 2012 Jun; 27(6):2425-9. PubMed ID: 22207330
[TBL] [Abstract][Full Text] [Related]
11. Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: a community hospital experience.
Agrawal V; Mukherjee S; Kosuri R; Dumler F
Am J Ther; 2010; 17(5):469-75. PubMed ID: 19770634
[TBL] [Abstract][Full Text] [Related]
12. [New treatments of anemia in chronic renal failure].
Fernández Lorente L; Romero R
Med Clin (Barc); 2014 Jul; 143(1):39-42. PubMed ID: 24467877
[No Abstract] [Full Text] [Related]
13. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.
To LL; Stoner CP; Stolley SN; Buenviaje JD; Ziegler TW
Am J Health Syst Pharm; 2001 Nov; 58(21):2061-5. PubMed ID: 11715828
[No Abstract] [Full Text] [Related]
14. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.
Joy MS; Candiani C; Vaillancourt BA; Chin H; Hogan SL; Falk RJ
Pharmacotherapy; 2007 May; 27(5):734-44. PubMed ID: 17461709
[TBL] [Abstract][Full Text] [Related]
15. Understanding epoetin use: databases or clinical trials?
Roger SD
Nephrology (Carlton); 2007 Apr; 12(2):118-9. PubMed ID: 17371331
[No Abstract] [Full Text] [Related]
16. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of renal anemia in hemodialysis patients in General Hospital Bjelovar from 2007 to 2010].
Lovcić V; Vujić J; Basić-Jukić N; Kurtović I; Janković RI; Lovcić P; Dzapo M
Acta Med Croatica; 2011 Oct; 65 Suppl 3():49-53. PubMed ID: 23120816
[TBL] [Abstract][Full Text] [Related]
18. [Feasibility strategy of darbepoetin alfa administration every other week: 2005-2007 experience in a dialysis unit].
Rottembourg JB; Dansaert A
Nephrol Ther; 2011 Dec; 7(7):549-57. PubMed ID: 21622039
[TBL] [Abstract][Full Text] [Related]
19. Assessing hyporesponse to Epoetin alfa: an algorithm approach: case study of the anemic patient.
Wingard R
Nephrol Nurs J; 2000 Oct; 27(5):517-20. PubMed ID: 16649327
[TBL] [Abstract][Full Text] [Related]
20. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.
Chan K; Moran J; Hlatky M; Lafayette R
Nephrol Dial Transplant; 2009 Jun; 24(6):1956-62. PubMed ID: 19176685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
